Work

Abstract A095: Tolerability and ocular adverse events of Datopotamab Deruxtecan in advanced cancers: A meta-analysis of phase III trials

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a095

Authors: Daniel Thomas. Jones, Ramaditya Srinivasmurthy, Jason Ta, Rishi Kumar. Nanda, Abbas Hussain, Riccesha Hattin, Kyaw Zin. Thein

Institutions: Mount Sinai Hospital, University of South Florida, HCA Healthcare, Touro University Nevada, University of Nevada, Las Vegas, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Drug-Induced Ocular Toxicity

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444336

FWCI:

Cites:

Cited by:

Related to: